Multivessel coronary thrombosis treated with abciximab (ReoPro(®)) in a patient with essential thrombocythemia

Clinical Cardiology

Volumn 21, Issue 2, 1998, Pages 134-138

  Michaels, Andrew D ^a   Whisenant, Brian ^a   Macgregor, John S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Abciximab; Acute myocardial infarction; Essential thrombocythemia; Multivessel coronary thrombosis; Primary angioplasty; ReoPro ; Thrombocytosis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; HEPARIN; HYDROXYUREA;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CORONARY ARTERY THROMBOSIS; DISEASE ASSOCIATION; HEART INFARCTION; HUMAN; MALE; PATHOPHYSIOLOGY; SPLENOMEGALY; THROMBOCYTHEMIA; THROMBOCYTOSIS; TREATMENT OUTCOME;

EID: 0031938797     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960210218     Document Type: Article

References (36)

1. Fialkow PJ, Faguet GB, Jacobson RJ, Vaidya K, Murphy S: Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood 1981;58:916-919
2. Mitus AJ, Barbui T, Shulman LN, Rosenthal DS, Viero P, Cortelazzo S, Schafer AI: Hemostatic complications in young patients with essential thrombocythemia. Am J Med 1990;88:371-375
3. Murphy MF, Clarke CR, Brearley BL: Superior sagittal sinus thrombosis and essential thrombocythaemia. Br Med J 1983; 287:1344
4. Walther EU, Tiecks FP, Haberl RL: Cranial sinus thrombosis associated with essential thrombocythemia followed by heparin-associated thrombocytopenia. Neurology 1996;47:300-301
5. Falconer J, Pineo G, Blahey W, Bowen T, Docksteader B, Jadusingh I: Essential thrombocythemia associated with recurrent abortions and fetal growth retardation. Am J Hematol 1987;25:345-347
6. Mercer, B, Drouin J, Jolly E, d'Anjou G: Primary thrombocythemia in pregnancy: A report of two cases. Am J Obstet Gynecol 1988;159:127-128
7. Davis RB: Acute thrombotic complications of myeloproliferative disorders in young adults. Am J Clin Pathol 1985;84:180-185
8. McIntyre KJ, Hoagland HC, Silverstein MN, Petitt RM. Essential thrombocythemia in young adults. Mayo Clin Proc 1991: 66;149-154
9. Randi ML, Fabris F, Tison T, Barbone E, Rossi C, Giralami A: Prevalence of specific thrombotic accidents in patients with thrombocytosis. Haematology 1993;25:149-152
10. Johnson M, Gernsheimer T, Johansen K: Essential thrombocytosis: Underemphasized cause of large-vessel thrombosis. J Vasc Surg 1995;22:443-447
11. Spach MS, Howell DA, Harris JS: Myocardial infarction and multiple thrombosis in a child with primary thrombocytosis. Pediatrics 1963;31:268-276
12. Virmani R, Popovsky MA, Roberts WC: Thrombocytosis, coronary thrombosis and acute myocardial infarction. Am J Med 1979; 67:498-506
13. Okayasu N, Murata M, Ueda A, Su KM, Sada T, Ito T, Hasegawa Y, Matsumoto S, Ito Y: Primary thrombocythemia and myocardial infarction in a 26-year-old woman with normal coronary angiogram. Jpn Heart J 1981;22:439-445
14. Saffitz JE, Phillips ER, Temesy-Armos PN, Roberts WC: Thrombocytosis and fatal coronary heart disease. Am J Cardiol 1983; 52:651-652
15. Takahashi H, Koeda T, Usui Y, Nakai K, Doijiri K, Honma H, Ichikawa T, Kato M: A case of essential hemorrhagic thrombocythemia associated with subendocardial infarction and acute renal failure. J Jpn Intern Med 1983;72:569-575 (in Japanese)
16. Douste-Blazy P, Taudou MJ, Delay M, Pris J, Sie P, Ribaut L, Galinier F, Bernadet P: Essential thrombocythaemia and recurrent myocardial infarction (letter). Lancet 1984;27:992
17. Yano, K, Takeyama HJ, Watanabe E, Kataoka T, Statke T: A case of essential thrombocythemia associated with myocardial and cerebral infarction. Naika 1986;57:177-179 (in Japanese)
18. Ushiyama K, Aoki Y, Ninomiya H, Nagasawa T, Abe T, Yanagisawa G: A case of essential thrombocythemia with acute myocardial infarction. Naika 1987;60:1399-1402 (in Japanese)
19. Louwerenburg JW, Suttorp MJ, Kingma JH: Aspirin withdrawal in a patient with essential thrombocythemia: Possible cause of myocardial infarction (letter). Am J Med 1987;83:1175
20. Suzuki A, Suzuki F, Takahata H, Igarashi K, Hirosaka A, Takezawa M, Kimura H, Kariyone S: Essential thrombocythemia associated with myocardial infarction - a case report. Shinzo 1988;20: 444-450 (in Japanese)
21. Hamada Y, Matsuda Y, Fujii B, Ohno H, Takashiba K, Ebihara H, Hyakuna E: Multiple coronary thrombosis in a patient with thrombocytosis. Clin Cardiol 1989;12:723-724
22. Furui J, Yamada Y, Tsuzuki M, Yamauchi K, Hayashi H, Saito H, Hasegawa S: A case of essential thrombocythemia associated with acute myocardial infarction. Shinzo 1990;22:180-184 (in Japanese)
23. Pick RA, Glover MU, Nanfro JJ, Dubbs WF, Gibbons JA, Vieweg WVR: Acute myocardial infarction with essential thrombocythemia in a young man. Am Heart J 1983;106:406-407
24. Momiyama T, Hiranaka T, Nomura F, Tominaga H, Nishioka T: Coronary artery bypass grafting for left main trunk coronary artery lesion associated with essential thrombocythemia. Clin Cardiol 1993;16:691-693
25. Kwaan HC, Suwanwela N: Inhibitors of fibrinolysis in platelets in polycythaemia vera and thrombocytosis. Br J Haematol 1971;21: 313-322
26. Wieczorek I, MacGregor IR, Ludlam CA: Low proteins C and S and activation of fibrinolysis in treated essential thrombocythemia. Am J Hematol 1995;49:277-281
27. Walsh PN, Murphy S, Barry WE: The role of platelets in the pathogenesis of thrombosis and hemorrhage in patients with thrombocytosis. Thromb Haemost 1977;38:1085-1096
28. Wanstrup J, Kjeldsen K, Astrup P: Acceleration of spontaneous intimal-subintimal changes in rabbit aorta by a prolonged moderate carbon monoxide exposure. Acta Pathol Microbiol Scand 1969; 75:353-362
29. Davis RB, Leuschen MP, Boyd D, Goodlin RC: Evaluation of platelet function in pregnancy: Comparative studies in non-smokers and smokers. Thromb Res 1987;46:175-186
30. Fuchs J, Weinberger I, Rotenberg Z, Erdberg A, Davidson E, Joshua H, Agmon J: Plasma viscosity in ischemic heart disease. Am Heart J 1984;108:435-439
31. EPIC Investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961
32. Lefkovits J, Plow EF, Topol EJ: Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995;332: 1553-1559
33. Tefferi A, Hoagland HC: Issues in the diagnosis and treatment of essential thrombocytosis. Mayo Clin Proc 1994;69:651-655
34. Cortelazzo S, Finazzi G, Ruggari M, Vestri O, Galli M, Rodeghiero F, Barbui T: Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med 1995;332: 1132-1136
35. Kleiman NS, Raizner AE, Jordan R, Wang AL, Norton D, Mace KF, Joshi A, Coller BS, Weisman HF: Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: Implications for inhibition of the internal pool of GPIIb/IIIa receptors. J Am Coll Cardiol 1995;26:1665-1671
36. Tcheng JE, Ellis SG, George BS, Kereiakes DJ, Kleiman NS, Talley JD, Wang AL, Weisman HF, Califf RM, Topol EJ: Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody 7E3 in high-risk coronary angioplasty. Circulation 1994; 90:1757-1764